Biopsy type disparities in patients with melanoma: Who receives the standard of care?

David J. Restrepo, Maria T. Huayllani, Daniel Boczar, Andrea Sisti, Emmanuel Gabriel, Riccardo Lemini, Aaron C. Spaulding, Sanjay Bagaria, Oscar J. Manrique, Antonio J. Forte

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Background/Aim: To analyze whether demographic and facility type characteristics cause inequality in the type of biopsy performed in patients with cutaneous melanoma. Patients and Methods: The skin cancer National Cancer Database was assessed. Men and women of all ages with cutaneous melanoma in situ and malignant melanoma at any stage of the disease were included. Patients were selected who underwent one of the following biopsy types: excisional, punch, shave, or incisional. Bivariate and multivariate analyses were performed. Results: We found that the likelihood of undergoing an excisional biopsy decreased in patients who were: Hispanic [odds ratio (OR)=0.63, confidence interval (CI)=0.55-0.71], non-White (OR=0.66, CI=0.58-0.76), older than 80 years (OR=0.77, CI=0.72-0.87), or in Comprehensive Community Cancer Programs (OR=0.33, CI=0.31-0.36), Community Cancer Programs (OR=0.52, CI=0.50-0.54) and Integrated Network Cancer Programs (OR=0.58, CI=0.55-0.61). Conclusion: Our study results demonstrate disparities in biopsy type in the treatment of melanoma.

Original languageEnglish (US)
Pages (from-to)6359-6363
Number of pages5
JournalAnticancer research
Issue number11
StatePublished - 2019


  • Biopsy
  • Disparities
  • Melanoma
  • Socioeconomic factors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Biopsy type disparities in patients with melanoma: Who receives the standard of care?'. Together they form a unique fingerprint.

Cite this